Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 132,040 | 0 | 0 | 0 | 88,820 |
| Depreciation Amortization | 170,840 | 0 | 0 | 0 | 159,790 |
| Other Working Capital | 40,420 | 0 | 0 | 0 | 16,650 |
| Other Operating Activity | -33,960 | 0 | 0 | 0 | -12,540 |
| Operating Cash Flow | $309,340 | $0 | $0 | $0 | $252,720 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -71,750 | 0 | 0 | 0 | -37,720 |
| Net Acquisitions | -647,170 | 0 | 0 | 0 | -520,770 |
| Other Investing Activity | 561,280 | 0 | 0 | 0 | -130,980 |
| Investing Cash Flow | $-157,640 | $0 | $0 | $0 | $-689,470 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 104,880 | 0 | 0 | 0 | 232,870 |
| Financing Cash Flow | $104,880 | $0 | $0 | $0 | $232,870 |
| Exchange Rate Effect | -19,750 | 0 | 0 | 0 | 5,260 |
| Beginning Cash Position | 198,390 | 0 | 0 | 0 | 397,010 |
| End Cash Position | 435,230 | 0 | 0 | 0 | 198,390 |
| Net Cash Flow | $236,830 | $0 | $0 | $0 | $-198,610 |
| Free Cash Flow | |||||
| Operating Cash Flow | 309,340 | 0 | 0 | 0 | 252,720 |
| Free Cash Flow | 309,340 | 0 | 0 | 0 | 252,720 |